- Home
- PLUR vs NAAS Comparison
PLUR vs NAAS Comparison
Compare PLUR & NAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLUR | NAAS |
|---|---|---|
| Founded | 2001 | 2019 |
| Country | Israel | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.4M | 33.8M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | PLUR | NAAS |
|---|---|---|
| Price | $3.31 | $3.14 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | 9.9K | ★ 23.6K |
| Earning Date | 02-06-2026 | 03-31-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,326,000.00 | ★ $21,817,052.00 |
| Revenue This Year | $97.38 | $378.49 |
| Revenue Next Year | $293.97 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 121.74 | N/A |
| 52 Week Low | $2.82 | $1.96 |
| 52 Week High | $7.13 | $40.32 |
Technical Indicators
Market Signals| Indicator | PLUR | NAAS |
|---|---|---|
| Relative Strength Index (RSI) | 54.54 | 43.38 |
| Support Level | $3.00 | $2.71 |
| Resistance Level | $3.50 | $3.20 |
| Average True Range (ATR) | 0.16 | 0.19 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 65.00 | 46.58 |
Price Performance
Historical ComparisonAbout PLUR Pluri Inc.
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.
About NAAS NaaS Technology Inc.
Naas Technology Inc is an electric vehicle charging service provider in China, whose vision is to power the world with carbon-neutral energy. It offers an integrated set of online solutions to charging station operators, a wide range of offline services that simplify the daily operations of charging station operators, and non-charging services such as food and beverage services to station operators.